ERBB2 and cancer: To this end we screened the enriched phage pool from the protein screen against monolayers of fixed cancer cells expressing moderate levels of HER2 (MDA-MB-453; Figure S1) with a HER2-negative cell line (MCF-7) as negative selection pan.